Table 1. Study design and animals.
Group | Treatment | Virus Inoculation | Number of Animals (n) | Animal ID |
---|---|---|---|---|
α-CD8/NK Ctrl uninfected | M-T807R1 | none | 2 | H28W |
ZN19 | ||||
IgG WT | IgG1 OKT3 | HTLV-1WT | 2 | H28P |
HFM | ||||
α-CD8 WT | CD8β255R1 | HTLV-1WT | 3 | ZL54 |
ZN25 | ||||
ZN28 | ||||
α-CD8 p12KO | CD8β255R1 | HTLV-1p12KO | 4 | ZL49 |
ZN17 | ||||
ZN12 | ||||
H861A | ||||
α-CD8/NK WT | M-T807R1 | HTLV-1WT | 3 | ZM32 |
ZN36 | ||||
ZN01 | ||||
α-CD8/NK p12KO | M-T807R1 | HTLV-1p12KO | 4 | HXR |
HRC | ||||
ZN23 | ||||
H16X | ||||
Liposome WT | Encapsome | HTLV-1WT | 3 | ZJ11 |
ZJ58 | ||||
H28J | ||||
Clodronate WT | Clodrosome | HTLV-1WT | 5 | ZJ22 |
Zi51 | ||||
HPM | ||||
P651 | ||||
R257 | ||||
Clodronate p12KO | Clodrosome | HTLV-1p12KO | 5 | M616 |
P205 | ||||
P206 | ||||
P212 | ||||
P213 |